AVIR Atea Pharmaceuticals Inc

USD 3.12 0.00 0
Icon

Atea Pharmaceuticals Inc (AVIR) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Sell

Average Analyst
Rating
stockTargetAdvisor

Sell

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 3.12

0.00 (0.00)%

USD 0.26B

0.41M

USD 0.00(+0.00%)

USD 78.00 (+2400.00%)

Icon

AVIR

Atea Pharmaceuticals Inc (USD)
COMMON STOCK | NSD
USD 3.12
0.00 0
Take a Tour
stockTargetAdvisor

Sell

Average Analyst
Rating
stockTargetAdvisor

Sell

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.26B

USD 78.00 (+2400.00%)

USD 3.12

Atea Pharmaceuticals Inc (AVIR) Stock Forecast

Show ratings and price targets of :
N/A
(+0.00%)

Based on the Atea Pharmaceuticals Inc stock forecast from 1 analysts, the average analyst target price for Atea Pharmaceuticals Inc is not available over the next 12 months. Atea Pharmaceuticals Inc’s average analyst rating is Sell. Stock Target Advisor’s own stock analysis of Atea Pharmaceuticals Inc is Neutral, which is based on 6 positive signals and 6 negative signals. At the last closing, Atea Pharmaceuticals Inc’s stock price was USD 3.12. Atea Pharmaceuticals Inc’s stock price has changed by +9.47% over the past week, -4.59% over the past month and -35.00% over the last year.

No recent analyst target price found for Atea Pharmaceuticals Inc
No recent average analyst rating found for Atea Pharmaceuticals Inc

Company Overview Atea Pharmaceuticals Inc

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an oral antiviral candidate that is in Phase ...Read More

https://ateapharma.com

125 Summer Street, Boston, MA, United States, 02110

74

December

USD

USA

Adjusted Closing Price for Atea Pharmaceuticals Inc (AVIR)

Loading...

Unadjusted Closing Price for Atea Pharmaceuticals Inc (AVIR)

Loading...

Share Trading Volume for Atea Pharmaceuticals Inc Shares

Loading...

Compare Performance of Atea Pharmaceuticals Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for AVIR

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Atea Pharmaceuticals Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc 0.00 (0.00%) USD90.24B 26.31 16.84

ETFs Containing AVIR

Symbol Name AVIR's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Atea Pharmaceuticals Inc (AVIR) Stock

Unfortunately we do not have enough data on AVIR's stock to indicate if its a good dividend stock.

Based on targets from 1 analysts, the average taret price for AVIR is USD 0.00 over the next 12 months. The maximum analyst target price is USD while the minimum anlayst target price is USD .

AVIR stock's Price/Earning ratio is 9.85. Our analysis grades AVIR stock's Price / Earning ratio at F. This means that AVIR stock's Price/Earning ratio is above 57.00000000000001% of the stocks in the Biotechnology sector in the NSD exchange. Based on this AVIR may be a overvalued for its sector.

The last closing price of AVIR's stock was USD 3.12.

The most recent market capitalization for AVIR is USD 0.26B.

Based on targets from 1 analysts, the average taret price for AVIR is projected at USD 0.00 over the next 12 months. This means that AVIR's stock price may go up by +0.00% over the next 12 months.

A PHP Error was encountered

Severity: Warning

Message: Undefined variable $etfs_link

Filename: stock-details/faqs.php

Line Number: 256

Backtrace:

File: /var/www/html/stocktarget/application/views/stock-details/faqs.php
Line: 256
Function: _error_handler

File: /var/www/html/stocktarget/application/views/stock-details/stock-detailss.php
Line: 2400
Function: include

File: /var/www/html/stocktarget/application/controllers/Stock_details.php
Line: 853
Function: view

File: /var/www/html/stocktarget/index.php
Line: 322
Function: require_once

We can't find any ETFs which contains Atea Pharmaceuticals Inc's stock.

As per our most recent records Atea Pharmaceuticals Inc has 74 Employees.

Atea Pharmaceuticals Inc's registered address is 125 Summer Street, Boston, MA, United States, 02110. You can get more information about it from Atea Pharmaceuticals Inc's website at https://ateapharma.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...